Latest Breaking News On - Bohin alban dufumier - Page 3 : comparemela.com

Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Mnémonique: ALOPM) (Paris:ALOPM),a biopharmaceutical company specializing in precision medicine for the treatment of resistant

France generalArthur rouillMathilde bohin alban dufumierPhilippe genneSchwierige zeitenRegulatory newsPrecision medicineGeneral meetingHalf resultsOncodesign precision medicineBohin alban dufumier